Clinical Trial Update: Randomized Phase I/II of RAD001 in Advanced Hepatocellular Carcinoma (HCC) [Phase 1, Phase 2]

View source ↗

Summary

A randomized phase I/II trial of RAD001 (everolimus) in advanced hepatocellular carcinoma is ongoing, with the current status listed as UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• RAD001 (everolimus)

Snippet

Sponsor: National Health Research Institutes, Taiwan | Conditions: Hepatocellular Carcinoma | Phase 1, Phase 2 | Status: UNKNOWN